A new Johns Hopkins study shows that data gathered from wearable activity trackers can be used to obtain several metrics associated with the user's general physical health and cardiovascular health status. While these sensors ...
Nov 17, 2022
0
4
Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target cancer cells and leave healthy tissues unharmed. Scientists have dubbed this type of targeted approach a "prodrug"—a medicine designed ...
Nov 16, 2022
0
1583
Predicting which patients will respond well to treatment is a quandary that has plagued the field of cancer immunotherapy for more than four decades. Now, researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel ...
Nov 16, 2022
0
40
New research findings show how higher viscosity, or resistance to flow, of the extracellular fluid that surrounds cells enables cancer cells to migrate more rapidly from a primary tumor to other sites in the body.
Nov 2, 2022
0
38
In a new study with obese mice, Johns Hopkins Medicine researchers say they have added to evidence that specialized channel proteins are possible therapeutic targets for sleep apnea and similar abnormally slow breathing disorders ...
Oct 31, 2022
0
36
In a study using specialized imaging techniques, Johns Hopkins Medicine researchers report distinctive changes in the "white matter" and other brain tissue physiology of those with post-treatment Lyme disease, a condition ...
Oct 26, 2022
0
778
Researchers from Johns Hopkins Medicine have discovered that the organization of different types of immune cells within pancreatic tumors is associated with how well patients with pancreatic cancer respond to treatment and ...
Oct 6, 2022
0
53
A study led by Johns Hopkins Medicine researchers discovered that communication among cells is altered in pregnant women who go on to develop postpartum depression (PPD) after giving birth.
Oct 4, 2022
0
54
In a study of more than 80 men and women from Baltimore, Maryland, Johns Hopkins researchers have added to evidence that COVID-19 booster shots are essential for maintaining long-term immunity against infection, particularly ...
Sep 29, 2022
0
22
It may soon be possible to identify Group 4 medulloblastomas—the most common malignant brain tumor in children—from more aggressive Group 3 tumors. Research based on a little-explored part of RNA, which creates proteins, ...
Sep 21, 2022
0
3
